Healthcare provider profile · identity verified

Nelson Carrasquillo Falcon, MD

Allopathic & Osteopathic Physicians|General Practice · CIDRA, PR · NPI 1801986609

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Nelson Carrasquillo Falcon, MD received $28.07 in general payments during 2025 across 1 reported records.

Boehringer Ingelheim Pharmaceuticals, Inc. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 1 associated product.

A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.

Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 25 claims for Jardiance by this doctor in 2024.

Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNJARDY as an associated drug or biological on 33 records involving 33 distinct recipient NPIs. Public Medicare Part D data also shows 33 claims for Synjardy by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$28.07

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Boehringer Ingelheim Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$28.07	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$28.07	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
JARDIANCE Normalized: jardiance	Drug	Boehringer Ingelheim Pharmaceuticals, Inc.	$28.07	1	2025
Source payment records 2025-03-05 · Boehringer Ingelheim Pharmaceuticals, Inc. · $28.07 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
JARDIANCE jardiance	2025	Jardiance	2024	25	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583	Jardiance · 2024 Exact normalized brand match · 1 Part D row	25	13
Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference	2025	SYNJARDY open payments reported associated product	CMS Open Payments — General Payments 33 supporting records · 33 recipient NPIs · example record 1222725005	Synjardy · 2024 Exact normalized brand match · 1 Part D row	33	13

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Simvastatin	Simvastatin	532	185
Rosuvastatin Calcium	Rosuvastatin Calcium	469	190
Clonazepam	Clonazepam	436	111
Losartan Potassium	Losartan Potassium	415	139
Atorvastatin Calcium	Atorvastatin Calcium	373	130
Gabapentin	Gabapentin	358	129
Famotidine	Famotidine	349	124
Synthroid	Levothyroxine Sodium	325	99
Amlodipine Besylate	Amlodipine Besylate	324	113
Metformin Hcl	Metformin Hcl	319	108
Pantoprazole Sodium	Pantoprazole Sodium	311	100
Metoprolol Succinate	Metoprolol Succinate	300	103
Pioglitazone Hcl	Pioglitazone Hcl	285	95
Sertraline Hcl	Sertraline Hcl	250	107
Omeprazole	Omeprazole	246	79
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	239	73
Levothyroxine Sodium	Levothyroxine Sodium	220	68
Lisinopril	Lisinopril	192	63
Montelukast Sodium	Montelukast Sodium	189	76
Temazepam	Temazepam	177	39
Amitriptyline Hcl	Amitriptyline Hcl	172	74
Ramipril	Ramipril	168	61
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	138	60
Duloxetine Hcl	Duloxetine Hcl	138	70
Meloxicam	Meloxicam	131	75
Clopidogrel	Clopidogrel Bisulfate	128	39
Glimepiride	Glimepiride	124	43
Baclofen	Baclofen	123	69
Nabumetone	Nabumetone	123	49
Fluconazole	Fluconazole	118	64
Carvedilol	Carvedilol	117	37
Diclofenac Potassium	Diclofenac Potassium	113	64
Trazodone Hcl	Trazodone Hcl	110	53
Lantus	Insulin Glargine,hum.Rec.Anlog	107	35
Tamsulosin Hcl	Tamsulosin Hcl	103	38
Hydrochlorothiazide	Hydrochlorothiazide	102	45
Furosemide	Furosemide	101	39
Alprazolam	Alprazolam	94	14
Atenolol	Atenolol	94	27
Albuterol Sulfate Hfa	Albuterol Sulfate	93	42
Ketoconazole	Ketoconazole	93	40
Tramadol Hcl	Tramadol Hcl	93	25
Alendronate Sodium	Alendronate Sodium	89	39
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	88	26
Lorazepam	Lorazepam	88	16
Zolpidem Tartrate	Zolpidem Tartrate	86	13
Ezetimibe	Ezetimibe	81	30
Fluticasone Propionate	Fluticasone Propionate	81	29
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	79	12
Amoxicillin	Amoxicillin	74	64
Fluticasone Propionate Hfa	Fluticasone Propionate	74	31
Diclofenac Sodium Er	Diclofenac Sodium	72	24
Eliquis	Apixaban	68	28
Ciprofloxacin Hcl	Ciprofloxacin Hcl	66	58
Prednisone	Prednisone	66	42
Cilostazol	Cilostazol	65	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	63	56
Irbesartan	Irbesartan	61	26
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	61	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	60	20
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	59	31
Azithromycin	Azithromycin	58	48
Doxazosin Mesylate	Doxazosin Mesylate	55	19
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	55	20
Etodolac Er	Etodolac	52	25
Tizanidine Hcl	Tizanidine Hcl	52	23
Donepezil Hcl	Donepezil Hcl	50	28
Januvia	Sitagliptin Phosphate	49	17
Lansoprazole	Lansoprazole	49	14
Metoprolol Tartrate	Metoprolol Tartrate	48	16
Bupropion Xl	Bupropion Hcl	47	23
Quetiapine Fumarate	Quetiapine Fumarate	46	21
Naproxen	Naproxen	44	15
Pentoxifylline	Pentoxifylline	44	20
Fluoxetine Hcl	Fluoxetine Hcl	43	20
Synjardy Xr	Empagliflozin/Metformin Hcl	43	16
Meclizine Hcl	Meclizine Hcl	42	22
Dicyclomine Hcl	Dicyclomine Hcl	40	20
Janumet Xr	Sitagliptin Phos/Metformin Hcl	40	13
Mometasone Furoate	Mometasone Furoate	40	24
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	38	15
Fenofibrate	Fenofibrate	38	suppressed
Memantine Hcl	Memantine Hcl	38	16
Doxepin Hcl	Doxepin Hcl	37	13
Estazolam	Estazolam	37	suppressed
Paroxetine Hcl	Paroxetine Hcl	36	17
Sildenafil Citrate	Sildenafil Citrate	35	suppressed
Sucralfate	Sucralfate	35	15
Hydralazine Hcl	Hydralazine Hcl	34	11
Xarelto	Rivaroxaban	34	13
Sulindac	Sulindac	33	26
Synjardy	Empagliflozin/Metformin Hcl	33	13
Candesartan Cilexetil	Candesartan Cilexetil	32	16
Farxiga	Dapagliflozin Propanediol	32	16
Nitroglycerin	Nitroglycerin	32	12
Valsartan	Valsartan	32	15
Humalog	Insulin Lispro	30	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	30	25
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	30	16
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Levofloxacin	Levofloxacin	29	22
Terbinafine Hcl	Terbinafine Hcl	29	14
Acyclovir	Acyclovir	28	15
Pregabalin	Pregabalin	28	12
Sure Comfort	Syring-Needl,disp,insul,0.3 Ml	28	suppressed
Dexamethasone	Dexamethasone	27	21
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Hydrocortisone	Hydrocortisone	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	11
Jardiance	Empagliflozin	25	13
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	25	suppressed
Tradjenta	Linagliptin	25	suppressed
Diazepam	Diazepam	23	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Topiramate	Topiramate	23	suppressed
Clobetasol Propionate	Clobetasol Propionate	22	11
Finasteride	Finasteride	22	suppressed
Risperidone	Risperidone	22	11
Triamcinolone Acetonide	Triamcinolone Acetonide	22	13
Aripiprazole	Aripiprazole	21	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	13
Ceftriaxone	Ceftriaxone Sodium	21	17
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	21	13
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Allopurinol	Allopurinol	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	20	13
Primidone	Primidone	20	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	15
Celecoxib	Celecoxib	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	15	suppressed
Brilinta	Ticagrelor	14	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	14	13
Lamotrigine	Lamotrigine	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Rivastigmine	Rivastigmine	14	suppressed
Sure Comfort	Syringe And Needle,insulin,1ml	14	suppressed
Tadalafil	Tadalafil	14	suppressed
Jentadueto	Linagliptin/Metformin Hcl	13	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	13	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$28.07 · 1 records	Boehringer Ingelheim Pharmaceuticals, Inc.	JARDIANCE	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Jardiance play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Boehringer Ingelheim Pharmaceuticals, Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error